SWS Hemodialysis Care Co., Ltd. (SHA:688410)
China · Delayed Price · Currency is CNY 10.76
+0.46 (4.47%)
At close: Jul 13, 2026
SWS Hemodialysis Care Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 847.11 | 806.74 | 567.1 | 689.96 | 381.89 | 283.1 |
Other Revenue | 0.16 | 0.16 | 0.18 | 0.15 | 0.12 | 0.17 |
| 847.27 | 806.91 | 567.27 | 690.11 | 382.01 | 283.28 | |
Revenue Growth (YoY) | 42.53% | 42.24% | -17.80% | 80.65% | 34.86% | 11.35% |
Cost of Revenue | 413.48 | 411.24 | 320.46 | 354.38 | 217.09 | 168.83 |
Gross Profit | 433.8 | 395.67 | 246.81 | 335.73 | 164.93 | 114.44 |
Selling, General & Admin | 207.06 | 187.33 | 157.6 | 132.21 | 97.7 | 80.34 |
Research & Development | 61.24 | 62.78 | 54.24 | 37.67 | 23.13 | 17.74 |
Other Operating Expenses | -20.12 | -19.01 | -11.34 | -17.35 | -8.68 | -4.77 |
Operating Expenses | 250.59 | 233.78 | 198.77 | 155.93 | 115.29 | 95.22 |
Operating Income | 183.21 | 161.89 | 48.04 | 179.8 | 49.64 | 19.23 |
Interest Expense | -0.22 | -0.28 | -0.28 | -0.16 | -0.8 | -1.61 |
Interest & Investment Income | 14.31 | 16.23 | 25.56 | 25.72 | 2.61 | 4.8 |
Currency Exchange Gain (Loss) | -1.28 | -1.28 | 0.93 | 0.68 | 0.74 | -0.2 |
Other Non Operating Income (Expenses) | 3.33 | -0.43 | -0.58 | 2.67 | -1.05 | -0.74 |
EBT Excluding Unusual Items | 199.34 | 176.13 | 73.68 | 208.71 | 51.14 | 21.48 |
Gain (Loss) on Sale of Investments | 11.03 | 9.47 | 9.14 | 10.79 | 0.78 | - |
Gain (Loss) on Sale of Assets | -1.6 | -1.4 | -0.28 | 0.45 | -0.34 | 0.04 |
Asset Writedown | -13.14 | -11.6 | -8.01 | - | - | -0.05 |
Other Unusual Items | -9.41 | -7.84 | -6.11 | - | 11.77 | 0.59 |
Pretax Income | 186.22 | 164.75 | 68.42 | 219.95 | 63.36 | 22.05 |
Income Tax Expense | 24.41 | 20.51 | 4.42 | 27.74 | 6.46 | 3.91 |
Earnings From Continuing Operations | 161.81 | 144.24 | 64 | 192.21 | 56.9 | 18.14 |
Minority Interest in Earnings | 1.54 | 1.64 | 6.89 | 2.29 | 2.33 | 1.33 |
Net Income | 163.36 | 145.89 | 70.89 | 194.5 | 59.24 | 19.47 |
Net Income to Common | 163.36 | 145.89 | 70.89 | 194.5 | 59.24 | 19.47 |
Net Income Growth | 121.77% | 105.80% | -63.55% | 228.34% | 204.20% | -5.55% |
Shares Outstanding (Basic) | 445 | 445 | 448 | 450 | 450 | 337 |
Shares Outstanding (Diluted) | 445 | 445 | 448 | 450 | 450 | 337 |
Shares Change (YoY) | -0.25% | -0.55% | -0.51% | 0.01% | 33.27% | 10.50% |
EPS (Basic) | 0.37 | 0.33 | 0.16 | 0.43 | 0.13 | 0.06 |
EPS (Diluted) | 0.37 | 0.33 | 0.16 | 0.43 | 0.13 | 0.06 |
EPS Growth | 122.33% | 106.94% | -63.37% | 228.32% | 128.25% | -14.52% |
Free Cash Flow | 107.98 | 151.87 | 59.97 | -47.97 | 232.9 | 4.69 |
Free Cash Flow Per Share | 0.24 | 0.34 | 0.13 | -0.11 | 0.52 | 0.01 |
Dividend Per Share | 0.143 | 0.143 | 0.071 | 0.192 | - | - |
Dividend Growth | 100.14% | 100.14% | -62.77% | - | - | - |
Gross Margin | 51.20% | 49.04% | 43.51% | 48.65% | 43.17% | 40.40% |
Operating Margin | 21.62% | 20.06% | 8.47% | 26.05% | 13.00% | 6.79% |
Profit Margin | 19.28% | 18.08% | 12.50% | 28.18% | 15.51% | 6.87% |
Free Cash Flow Margin | 12.75% | 18.82% | 10.57% | -6.95% | 60.97% | 1.65% |
EBITDA | 202.4 | 181.13 | 67.47 | 196.03 | 63.94 | 32.99 |
EBITDA Margin | 23.89% | 22.45% | 11.89% | 28.41% | 16.74% | 11.65% |
D&A For EBITDA | 19.19 | 19.24 | 19.43 | 16.23 | 14.3 | 13.76 |
EBIT | 183.21 | 161.89 | 48.04 | 179.8 | 49.64 | 19.23 |
EBIT Margin | 21.62% | 20.06% | 8.47% | 26.05% | 13.00% | 6.79% |
Effective Tax Rate | 13.11% | 12.45% | 6.46% | 12.61% | 10.19% | 17.72% |
Revenue as Reported | 847.27 | 806.91 | 567.27 | 690.11 | 382.01 | 283.28 |